Mission/Background :
Our primary mission is to contribute to super-personalized medicine by providing platform technology on the immune system. There are huge issues as follows: drugs do not always have the desired effect and adverse drug events are among the leading causes of death. Approximately, half of global drug sales, corresponding to $500 billion per year, are wasted on ineffective treatments and more than 2.2 million severe adverse drug events occur each year in the United States including more than 100,000 deaths. By identifying each patient’s drug targets with our company’s two analysis platforms, which are immuno-profiling and somatic gene mutation analyses, we could appropriately combine existing standardized therapies and develop personalized therapies.